Novartis Launches Europe’s First Specialized Viral Vector Production Facility in Slovenia
Novartis has unveiled its first dedicated viral vector production facility in Slovenia, marking a bold leap forward in its European ...
Read moreNovartis has unveiled its first dedicated viral vector production facility in Slovenia, marking a bold leap forward in its European ...
Read moreThe Sandoz family has impressively raised CHF 2.6 billion by selling shares in Novartis, highlighting a surge of investor enthusiasm ...
Read moreM | T | W | T | F | S | S |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | ||
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 31 |
© 2024 EUROP.INFO - Copyright for syndicated content belongs to the linked Source.
© 2024 EUROP.INFO - Copyright for syndicated content belongs to the linked Source.